NM_005591.4(MRE11):c.1112dup (p.Gly372fs) AND Ataxia-telangiectasia-like disorder

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Feb 12, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001205827.6

Allele description [Variation Report for NM_005591.4(MRE11):c.1112dup (p.Gly372fs)]

NM_005591.4(MRE11):c.1112dup (p.Gly372fs)

Gene:

MRE11:MRE11 homolog, double strand break repair nuclease [Gene - OMIM - HGNC]

Variant type:

Duplication

Cytogenetic location:

11q21

Genomic location:

Preferred name:

NM_005591.4(MRE11):c.1112dup (p.Gly372fs)

HGVS:

NC_000011.10:g.94464227dup
NG_007261.1:g.34649dup
NM_001330347.2:c.1112dup
NM_005590.4:c.1112dup
NM_005591.4:c.1112dupMANE SELECT
NP_001317276.1:p.Gly372fs
NP_005581.2:p.Gly372fs
NP_005582.1:p.Gly372fs
LRG_85t1:c.1112dup
LRG_85:g.34649dup
NC_000011.9:g.94197391_94197392insC
NC_000011.9:g.94197393dup
NM_005591.3:c.1112dup

Protein change:

G372fs

Links:

dbSNP: rs1591681273

NCBI 1000 Genomes Browser:

rs1591681273

Molecular consequence:

NM_001330347.2:c.1112dup - frameshift variant - [Sequence Ontology: SO:0001589]
NM_005590.4:c.1112dup - frameshift variant - [Sequence Ontology: SO:0001589]
NM_005591.4:c.1112dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:: Ataxia-telangiectasia-like disorder (ATLD)
Identifiers:: MONDO: MONDO:0011457; MedGen: C1858391; OMIM: PS604391

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001377104	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Pathogenic (Feb 12, 2020)	germline	clinical testing	PubMed (3) [See all records that cite these PMIDs] 23080121, 23912341, 28492532

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001377104

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Pathogenic
(Feb 12, 2020)

germline

clinical testing

PubMed (3)
[See all records that cite these PMIDs]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Mre11 ATLD17/18 mutation retains Tel1/ATM activity but blocks DNA double-strand break repair.

Limbo O, Moiani D, Kertokalio A, Wyman C, Tainer JA, Russell P.

Nucleic Acids Res. 2012 Dec;40(22):11435-49. doi: 10.1093/nar/gks954. Epub 2012 Oct 17.

PubMed [citation]

PMID:: 23080121
PMCID:: PMC3526295

Disease-associated MRE11 mutants impact ATM/ATR DNA damage signaling by distinct mechanisms.

Regal JA, Festerling TA, Buis JM, Ferguson DO.

Hum Mol Genet. 2013 Dec 20;22(25):5146-59. doi: 10.1093/hmg/ddt368. Epub 2013 Aug 2.

PubMed [citation]

PMID:: 23912341
PMCID:: PMC3842175

See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001377104.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MRE11 are known to be pathogenic (PMID: 23080121, 23912341). This variant has not been reported in the literature in individuals with MRE11-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly372Argfs*3) in the MRE11 gene. It is expected to result in an absent or disrupted protein product.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine